Roger A. Barker spends much of his time researching Parkinson's disease, Neuroscience, Internal medicine, Disease and Huntington's disease. His work deals with themes such as Dopaminergic, Dopamine, Psychiatry, Cognition and Dementia, which intersect with Parkinson's disease. His biological study spans a wide range of topics, including Cohort and Risk factor.
His studies in Internal medicine integrate themes in fields like Endocrinology, Oncology and Genotype. Roger A. Barker has researched Disease in several fields, including Genetics, Quality of life and Bioinformatics. His Huntington's disease research is multidisciplinary, relying on both Rating scale, Trinucleotide repeat expansion and Central nervous system disease, Degenerative disease.
Roger A. Barker mainly investigates Parkinson's disease, Neuroscience, Disease, Huntington's disease and Internal medicine. He interconnects Psychiatry, Cognition and Dementia in the investigation of issues within Parkinson's disease. His studies deal with areas such as Stem cell and Transplantation as well as Neuroscience.
His work in Disease tackles topics such as Cohort which are related to areas like Pediatrics and Cohort study. His studies in Huntington's disease integrate themes in fields like Central nervous system disease and Degenerative disease. The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine.
His main research concerns Parkinson's disease, Disease, Internal medicine, Neuroscience and Huntington's disease. His Parkinson's disease study integrates concerns from other disciplines, such as Cognition, Dopaminergic, Dopamine and Dementia. His biological study spans a wide range of topics, including Clinical trial, Bioinformatics and Proportional hazards model.
His Internal medicine research incorporates themes from Gastroenterology and Oncology. His research in Neuroscience intersects with topics in Induced pluripotent stem cell and Alpha-synuclein. His Huntington's disease research incorporates elements of Chorea, Cancer research and Trinucleotide repeat expansion.
Roger A. Barker mostly deals with Parkinson's disease, Disease, Internal medicine, Neuroscience and Clinical trial. His Parkinson's disease study combines topics from a wide range of disciplines, such as Dementia, Dopamine, Cognition and Cohort study. His research integrates issues of Cell, Bioinformatics and Anxiety in his study of Disease.
His work deals with themes such as Magnetic resonance imaging, Oncology and Pathology, which intersect with Internal medicine. Roger A. Barker has included themes like Reprogramming and Induced pluripotent stem cell in his Neuroscience study. His study in Clinical trial is interdisciplinary in nature, drawing from both Psychological intervention, Diversity, MEDLINE and Minimal risk.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines
Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand.
Movement Disorders (2012)
A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation
C. D. Clelland;M. Choi;C. Romberg;G. D. Clemenson.
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
C. H. Williams-Gray;T. Foltynie;C. E. G. Brayne;T. W. Robbins.
Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task Demands
Roshan Cools;Roger A. Barker;Barbara J. Sahakian;Trevor W. Robbins.
Cerebral Cortex (2001)
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease
Angie A Kehagia;Roger A Barker;Trevor W Robbins.
Lancet Neurology (2010)
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Caroline H. Williams-Gray;Jonathan R. Evans;An Goris;An Goris;Thomas Foltynie.
RNA velocity of single cells
Gioele La Manno;Gioele La Manno;Ruslan Soldatov;Amit Zeisel;Amit Zeisel;Emelie Braun;Emelie Braun.
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
Thomas Foltynie;Carol E. G. Brayne;Trevor W. Robbins;Roger A. Barker.
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.
D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub.
Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.
Simon J. G. Lewis;Anja Dove;Trevor W. Robbins;Roger A. Barker.
The Journal of Neuroscience (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: